PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.7062
+0.0243 (3.56%)
At close: May 12, 2025, 4:00 PM
0.6613
-0.0449 (-6.36%)
After-hours: May 12, 2025, 6:15 PM EDT
PAVmed Employees
PAVmed had 39 employees as of December 31, 2024. The number of employees decreased by 68 or -63.55% compared to the previous year.
Employees
39
Change (1Y)
-68
Growth (1Y)
-63.55%
Revenue / Employee
$76,795
Profits / Employee
$819,641
Market Cap
22.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PAVM News
- 11 days ago - PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 - PRNewsWire
- 12 days ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - PRNewsWire
- 18 days ago - NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - PRNewsWire
- 4 weeks ago - Lucid Diagnostics Announces Closing of Public Offering of Common Stock - PRNewsWire
- 4 weeks ago - Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PRNewsWire
- 4 weeks ago - Lucid Diagnostics Announces Proposed Public Offering of Common Stock - PRNewsWire
- 5 weeks ago - Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 6 weeks ago - Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology - PRNewsWire